- Benzinga•15 days ago
SCYNEXIS Inc (NASDAQ: SCYX ) witnessed volatile trading Thursday after the company announced the completion of its Phase two trial and the closing of a $15 million term loan with Solar Capital Ltd (NASDAQ: ...
- GlobeNewswire•16 days agoSCYNEXIS Announces Complete Results from Two Phase 2 Studies of Oral SCY-078 in Patients with Candida spp. Infections and Closing of a $15 Million Term Loan
Study Results Confirm Overall Antifungal Activity of Oral SCY-078 in Patients with Candida Infections. Well-Tolerated and Active Oral Dose of SCY-078 Identified for Invasive Candidiasis Patients. Evidence ...
Solar Capital Ltd. (SLRC)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||17.05 x 500|
|Day's Range||20.01 - 20.22|
|52wk Range||15.05 - 20.88|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||27.24|
|Avg Vol (3m)||108,392|
|Dividend & Yield||N/A (N/A)|